ArticleThe Prostate2025

Assessing the predictive value of intraductal carcinoma of the prostate (IDC-P) in determining abiraterone efficacy for metastatic hormone-sensitive prostate cancer (mHSPC) patients.

Xinyuan Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.